Loading clinical trials...

Active Not RecruitingPhase 1NCT04483440

Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia

This study will evaluate safety, tolerability, and preliminary efficacy of a single intravitreal (IVT) injection of a recombinant adeno-associated virus (AAV) gene therapy, 4D-110, in male patients wi...

Lead sponsor: 4D Molecular Therapeutics•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 1/2

An Open Label Clinical Trial of Retinal Gene Therapy for Choroideremia

NCT02077361 · Choroideremia

COMPLETEDPhase 2

REP1 Gene Replacement Therapy for Choroideremia

NCT02407678 · Choroideremia

COMPLETEDNA

Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy

NCT02670980 · Retinitis Pigmentosa, Cone Rod Dystrophy, and more

COMPLETEDNA

Pilot Study of a Suprachoroidal Retinal Prosthesis

NCT01603576 · Retinitis Pigmentosa, Choroideremia

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 22, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhasePHASE1

Enrollment13

Start dateJun 2020

Last updatedMay 22, 2025

Condition

Choroideremia

Locations shown

Retina Foundation of the Southwest

Dallas, Texas

Moran Eye Center, University of Utah

Salt Lake City, Utah

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 22, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions